ng-nitroarginine methyl ester has been researched along with Fatty Liver, Nonalcoholic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, M; Hirohata, S; Honma, K; Kakimoto, M; Kirihara, S; Kitamori, K; Kumazaki, S; Matsui, M; Nakayama, H; Ran, S; Sato, I; Shinohata, R; Usui, S; Watanabe, S; Yamamoto, S | 1 |
| Fujii, M; Fukuoka, T; Hirohata, S; Honma, K; Kakimoto, M; Kirihara, S; Nakayama, H; Sato, I; Tamura, S; Ueda, M; Watanabe, S; Yamamoto, S | 1 |
| Akiyama, N; Fukuhama, N; Hirohata, S; Kitamori, K; Kumazaki, S; Ran, S; Sakai, M; Sato, I; Watanabe, S; Yamamoto, S; Yamori, Y | 1 |
| Ikeda, T; Katsuragi, S; Kawamura, T; Maki, S; Tachibana, R; Takeuchi, H; Tanaka, H; Tanaka, K; Toriyabe, K; Yoshikawa, K | 1 |
| Hirohata, S; Kitamori, K; Kumazaki, S; Mori, M; Sato, I; Watanabe, S; Yamamoto, S; Yamori, Y | 1 |
| Shen, C; Wang, W; Wang, Y; Zhao, C; Zhen, Z; Zhou, J | 1 |
| Jenkins, NT; Laughlin, MH; Padilla, J; Rector, RS; Sheldon, RD | 1 |
| Jayachitra, J; Nalini, N; Shenbagam, M; Victor Antony Santiago, J | 1 |
8 other study(ies) available for ng-nitroarginine methyl ester and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Suppression of nitric oxide synthase aggravates non-alcoholic steatohepatitis and atherosclerosis in SHRSP5/Dmcr rat via acceleration of abnormal lipid metabolism.
Topics: Acceleration; Animals; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cholesterol; Diet, High-Fat; Lipid Metabolism; Liver; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Non-alcoholic Fatty Liver Disease; Rats; Rats, Inbred SHR | 2022 |
Therapeutic effect of ouabagenin, a novel liver X receptor agonist, on atherosclerosis in nonalcoholic steatohepatitis in SHRSP5/Dmcr rat model.
Topics: Animals; Atherosclerosis; Cholesterol; Diet, High-Fat; Endothelial Cells; Liver; Liver X Receptors; NG-Nitroarginine Methyl Ester; Non-alcoholic Fatty Liver Disease; Rats; Rats, Inbred SHR | 2023 |
Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in SHRSP5/Dmcr rat model.
Topics: Animals; Aorta; Bile Acids and Salts; Cardiovascular Diseases; Cholic Acid; Diet, High-Fat; Gene Expression Regulation; Humans; Lipid Metabolism; NF-kappa B; NG-Nitroarginine Methyl Ester; Non-alcoholic Fatty Liver Disease; Rats; Vascular Cell Adhesion Molecule-1 | 2020 |
Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring.
Topics: Adipocytes; Animals; Diet, High-Fat; Female; Fetal Development; Fetal Growth Retardation; Glucose Tolerance Test; Hypertension; Hypertrophy; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Non-alcoholic Fatty Liver Disease; Pregnancy; Prenatal Exposure Delayed Effects; Tadalafil | 2021 |
Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model.
Topics: Animals; Arteriosclerosis; Diet, High-Fat; Disease Models, Animal; Endothelium, Vascular; Heart Ventricles; Liver; Male; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Non-alcoholic Fatty Liver Disease; Organ Size; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Dysfunction, Left | 2018 |
Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis.
Topics: Actins; Animals; Cells, Cultured; Collagen Type I; Diet, High-Fat; Enzyme Inhibitors; Fatty Liver; Gene Expression; Hepatic Stellate Cells; Humans; Hypolipidemic Agents; Liver; Liver Cirrhosis; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Simvastatin; Transforming Growth Factor beta1 | 2013 |
Chronic NOS inhibition accelerates NAFLD progression in an obese rat model.
Topics: Adaptation, Physiological; Animals; Chemical and Drug Induced Liver Injury; Disease Progression; Eating; Enzyme Inhibitors; Inflammation Mediators; Insulin Resistance; Lipids; Liver; Liver Cirrhosis, Experimental; Macrophages; Mitochondria, Liver; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Non-alcoholic Fatty Liver Disease; Obesity; Rats, Inbred OLETF; Time Factors | 2015 |
Dietary d-limonene alleviates insulin resistance and oxidative stress-induced liver injury in high-fat diet and L-NAME-treated rats.
Topics: Animals; Antioxidants; Cyclohexenes; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Fatty Liver; Insulin; Insulin Resistance; Insulin Secretion; Limonene; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Metabolic Syndrome; NG-Nitroarginine Methyl Ester; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pancreas; Random Allocation; Rats; Rats, Wistar; Terpenes | 2012 |